Complete Filing Data
FENNEC PHARMACEUTICALS INC. reported Net Income Loss of -$9.74 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean FENNEC PHARMACEUTICALS INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2002 | FY2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$9.7M | -$436.0K | -$16.0M | -$23.7M | -$17.3M | -$18.1M | -$12.8M | -$9.9M | -$7.0M | -$2.8M | -$659.0K | -$2.2M | -$3.7M | |||||
| Operating Income Loss | -$6.3M | $2.6M | -$12.8M | -$22.6M | -$17.2M | -$17.9M | -$13.0M | -$10.4M | -$7.0M | -$2.9M | -$1.9M | -$2.9M | -$1.9M | -$3.6M | -$3.4M | -$4.6M | ||
| General And Administrative Expense | $28.3M | $23.1M | $20.6M | $17.7M | $12.2M | $13.0M | $7.4M | $5.4M | $5.0M | $2.4M | $1.6M | $2.5M | $1.3M | $1.5M | $1.9M | $3.9M | ||
| Nonoperating Income Expense | -$3.4M | -$2.6M | -$3.3M | -$1.1M | -$123.0K | -$224.0K | $234.0K | $521.0K | -$95.0K | $82.0K | $1.2M | $701.0K | $3.8M | -$1.5M | $8.1M | -$3.2M | ||
| Investment Income Nonoperating | $195.0K | $54.0K | $87.0K | $315.0K | $348.0K | $47.0K | $8.0K | $3.0K | $2.0K | $2.0K | $25.0K | $43.0K | $32.0K | |||||
| Revenues | $44.6M | $47.5M | $21.3M | $1.5M | $170.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Research And Development Expense | $250.0K | $307.0K | $56.0K | $3.5M | $5.0M | $5.1M | $5.6M | $5.0M | $1.9M | $472.0K | $256.0K | $357.0K | ||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $16.0K | |||||||||||||||||
| Other Nonoperating Income Expense | -$9.0K | -$17.0K | $6.0K | -$8.0K | -$14.0K | -$9.0K | ||||||||||||
| Research And Development Expense Excluding Acquired In Process Cost | $357.0K | $597.0K | $2.1M | $1.5M | $708.0K | |||||||||||||
| Operating Expenses | $50.9M | $45.0M | $34.0M | $24.0M | $17.2M | $18.1M | $13.0M | |||||||||||
| Other Nonoperating Income | -$3.0K | -$5.0K | $9.0K | |||||||||||||||
| Research And Development In Process | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Interest Expense | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Asset Impairment Charges | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Cost Of Goods And Services Sold | $1.3M | $86.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$638.0K | -$3.2M | -$1.2M | -$5.7M | -$5.6M | $12.8M | -$1.9M | -$5.4M | -$6.1M | -$8.1M | -$5.1M | -$3.7M | -$4.2M | -$4.0M | -$4.7M | -$6.2M | -$4.8M | -$3.8M | -$1.8M | -$4.7M | -$2.6M | -$2.7M | -$2.6M | -$1.6M | -$2.4M | -$1.6M | -$806.0K | -$1.1M | -$502.0K | -$724.0K | -$420.0K | -$540.0K | -$123.0K | -$173.0K | $177.0K | $380.0K | -$750.0K | -$3.2M | -$1.8M | $6.6M | -$4.1M | -$764.0K | -$602.0K | $2.7M | -$3.1M | -$348.0K | $4.7M | $1.7M | -$2.6M |
| Operating Income Loss | -$189.0K | -$2.7M | -$808.0K | -$5.2M | -$5.0M | $13.7M | -$1.0M | -$4.7M | -$5.3M | -$7.9M | -$5.0M | -$3.5M | -$4.2M | -$3.9M | -$4.9M | -$5.9M | -$4.8M | -$3.8M | -$1.9M | -$4.8M | -$2.7M | -$2.8M | -$2.7M | -$1.8M | -$2.2M | -$1.5M | -$771.0K | -$564.0K | -$707.0K | -$454.0K | -$338.0K | -$549.0K | -$452.0K | -$619.0K | -$930.0K | -$537.0K | -$51.0K | -$927.0K | -$537.0K | -$630.0K | -$1.3M | -$616.0K | -$944.0K | -$572.0K | -$1.0M | -$917.0K | -$2.5M | ||
| General And Administrative Expense | $6.8M | $7.0M | $6.1M | $6.1M | $6.9M | $5.9M | $3.8M | $5.5M | $4.3M | $7.1M | $3.9M | $2.1M | $2.9M | $3.1M | $2.5M | $4.5M | $3.7M | $2.4M | $1.1M | $2.8M | $1.0M | $1.1M | $1.9M | $1.1M | $1.7M | $1.1M | $546.0K | $452.0K | $568.0K | $407.0K | $250.0K | $495.0K | $409.0K | $531.0K | $858.0K | $505.0K | $275.0K | $373.0K | $359.0K | $273.0K | $390.0K | $320.0K | $505.0K | $338.0K | $706.0K | $807.0K | $2.4M | ||
| Nonoperating Income Expense | -$449.0K | -$420.0K | -$357.0K | -$533.0K | -$514.0K | -$906.0K | -$850.0K | -$778.0K | -$782.0K | -$190.0K | -$63.0K | -$150.0K | -$12.0K | -$81.0K | $190.0K | -$341.0K | $9.0K | $54.0K | $83.0K | $54.0K | $99.0K | $78.0K | $223.0K | -$166.0K | -$119.0K | -$35.0K | $62.0K | -$17.0K | $34.0K | $215.0K | $376.0K | $629.0K | $999.0K | $180.0K | -$2.7M | -$1.7M | $7.5M | -$3.6M | -$134.0K | $648.0K | $3.3M | -$2.2M | $224.0K | $5.7M | $2.6M | -$64.0K | |||
| Investment Income Nonoperating | $115.0K | $109.0K | $24.0K | $9.0K | $9.0K | $13.0K | $12.0K | $16.0K | $22.0K | $17.0K | $35.0K | $70.0K | $110.0K | $66.0K | $101.0K | $73.0K | $59.0K | $16.0K | $5.0K | $3.0K | $3.0K | $3.0K | $0.00 | $1.0K | $1.0K | $1.0K | $0.00 | $3.0K | -$2.0K | $0.00 | -$3.0K | $2.0K | $5.0K | $3.0K | $8.0K | $21.0K | -$1.0K | $10.0K | $13.0K | $8.0K | |||||||||
| Revenues | $12.5M | $9.7M | $8.8M | $7.0M | $7.3M | $25.4M | $6.5M | $3.3M | $1.7M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Research And Development Expense | $29.0K | $107.0K | $94.0K | $97.0K | $157.0K | $3.0K | $12.0K | $8.0K | $4.0K | $846.0K | $1.1M | $1.4M | $1.2M | $800.0K | $2.4M | $1.4M | $1.1M | $1.4M | $795.0K | $2.0M | $1.7M | $1.8M | $798.0K | $689.0K | $492.0K | $333.0K | $225.0K | $112.0K | $139.0K | $47.0K | $88.0K | $54.0K | $43.0K | $88.0K | $72.0K | ||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | |||||||||||||||||||||||||||||||||||||||||||||||||
| Other Nonoperating Income Expense | -$1.0K | -$8.0K | -$8.0K | $13.0K | -$9.0K | $1.0K | -$10.0K | $0.00 | -$2.0K | $5.0K | -$3.0K | $1.0K | -$4.0K | -$1.0K | $0.00 | -$3.0K | -$9.0K | -$2.0K | -$10.0K | $1.0K | -$4.0K | $0.00 | |||||||||||||||||||||||||||
| Research And Development Expense Excluding Acquired In Process Cost | $42.0K | $88.0K | $72.0K | $24.0K | -$224.0K | $554.0K | $178.0K | $357.0K | $860.0K | $296.0K | $439.0K | $234.0K | $315.0K | $110.0K | $146.0K | ||||||||||||||||||||||||||||||||||
| Operating Expenses | $12.7M | $12.4M | $9.6M | $12.2M | $12.3M | $11.6M | $7.5M | $8.0M | $6.9M | $7.9M | -$5.0M | $3.5M | $4.9M | $3.8M | $51.0K | $927.0K | $630.0K | $1.3M | $944.0K | $572.0K | $917.0K | $2.5M | |||||||||||||||||||||||||||
| Other Nonoperating Income | $3.0K | $1.0K | -$4.0K | $0.00 | -$7.0K | $2.0K | $0.00 | $0.00 | $0.00 | -$4.0K | $0.00 | $0.00 | $28.0K | ||||||||||||||||||||||||||||||||||||
| Research And Development In Process | $1.0K | $0.00 | $0.00 | $8.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||
| Interest Expense | $9.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||
| Asset Impairment Charges | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||
| Cost Of Goods And Services Sold | $331.0K | $148.0K | $95.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $35.5M | -$5.9M | -$11.6M | -$2.6M | $15.8M | $29.1M | $11.9M | $21.3M | $26.8M | $3.6M | $548.0K | $613.0K | -$1.5M | $47.0K | ||||
| Cash And Cash Equivalents At Carrying Value | $36.8M | $26.6M | $13.3M | $23.8M | $21.1M | $30.3M | $22.8M | $28.3M | $3.9M | $942.0K | $2.3M | $1.7M | $2.3M | $5.3M | $5.9M | $685.0K | ||
| Cash And Cash Equivalents Period Increase Decrease | -$5.5M | $24.3M | $3.0M | -$1.4M | $644.0K | -$640.0K | -$3.0M | -$650.0K | $5.3M | |||||||||
| Liabilities And Stockholders Equity | $70.6M | $44.9M | $26.9M | $26.9M | $22.4M | $31.4M | $14.1M | $23.0M | $28.4M | $4.0M | $1.0M | $2.4M | $1.8M | $2.4M | $5.4M | $6.0M | ||
| Common Stock Value | $189.9M | $145.6M | $144.3M | $142.6M | $140.8M | $140.7M | $106.4M | $106.4M | $103.0M | $74.5M | $69.4M | $68.7M | $66.8M | $66.0M | $66.0M | $64.9M | ||
| Additional Paid In Capital Common Stock | $73.7M | $67.0M | $62.1M | $56.8M | $53.2M | $49.2M | $48.3M | $44.9M | $43.8M | $42.1M | $41.4M | $41.6M | $39.2M | $38.4M | $38.1M | $37.7M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | ||
| Accrued Liabilities Current | $5.6M | $3.4M | $3.8M | $2.2M | $877.0K | $776.0K | $659.0K | $605.0K | $622.0K | $125.0K | $92.0K | $132.0K | $132.0K | $423.0K | $52.0K | $195.0K | ||
| Accounts Payable Current | $4.6M | $3.2M | $3.8M | $2.4M | $777.0K | $1.6M | $1.6M | $1.0M | $855.0K | $244.0K | $297.0K | $308.0K | $212.0K | $259.0K | $342.0K | $272.0K | ||
| Other Assets Current | $1.7M | $466.0K | $44.0K | $63.0K | $253.0K | $276.0K | $8.0K | $1.0K | $13.0K | $3.0K | $1.0K | $17.0K | $8.0K | $6.0K | $19.0K | $8.0K | ||
| Assets | $70.6M | $44.9M | $26.9M | $26.9M | $22.4M | $31.4M | $14.1M | $23.0M | $28.4M | $4.0M | $1.0M | $2.4M | $1.8M | $2.4M | $5.4M | $6.0M | ||
| Liabilities | $35.1M | $50.8M | $38.5M | $29.5M | $6.6M | $2.3M | $2.3M | $1.6M | $1.6M | $402.0K | $471.0K | $1.8M | $3.2M | $7.3M | $5.5M | $10.9M | ||
| Common Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Liabilities Current | $10.5M | $6.9M | $7.6M | $4.6M | $1.7M | $2.3M | $2.3M | $1.6M | $1.6M | $402.0K | $471.0K | $1.8M | $3.2M | $7.3M | $5.5M | $10.9M | ||
| Retained Earnings Accumulated Deficit | -$229.4M | -$219.7M | -$219.2M | -$203.2M | -$179.5M | -$162.1M | -$144.0M | -$131.3M | -$121.4M | -$114.3M | -$111.5M | -$110.9M | -$108.7M | |||||
| Derivative Liabilities Current | $0.00 | $167.0K | $33.0K | $82.0K | $1.3M | $2.9M | $6.6M | $5.1M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $10.2M | $13.4M | -$10.5M | $2.7M | -$9.2M | $16.7M | -$9.1M | -$5.5M | ||||||||||
| Repayments Of Long Term Debt | $19.5M | $13.0M | $5.0M | $0.00 | $0.00 | $0.00 | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $36.8M | $26.6M | $13.3M | $23.8M | $21.1M | $30.3M | $13.7M | |||||||||||
| Gain On Deferred Lease Inducements | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Repayments Of Other Debt | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Repayments Of Long Term Capital Lease Obligations | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 | Q1 2010 | Q4 2009 | Q4 2008 | Q4 2007 | Q4 2006 | Q4 2005 | Q4 2004 | Q2 2004 | Q2 2003 | Q2 2002 | Q2 2001 | Q3 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$4.5M | -$7.5M | -$5.9M | -$5.2M | -$1.4M | $3.0M | -$10.5M | -$9.7M | -$7.3M | $2.8M | $8.5M | $12.5M | $19.0M | $22.3M | $24.9M | $31.2M | $36.1M | $8.5M | $15.0M | $16.5M | $19.2M | $22.9M | $24.9M | $25.7M | $8.9M | $9.7M | $2.9M | $4.2M | $4.7M | $243.0K | $1.0M | $1.1M | $826.0K | -$3.2M | -$4.7M | -$4.3M | -$4.1M | -$2.4M | -$9.1M | -$5.0M | $1.3M | $2.0M | $2.6M | -$120.0K | -$3.7M | -$684.0K | -$283.0K | -$4.9M | $406.0K | $3.1M | $14.1M | $1.3M | $11.1M | $16.7M | $20.5M | $698.0K | $6.1M | $9.8M | ||||||
| Cash And Cash Equivalents At Carrying Value | $21.9M | $18.7M | $22.7M | $40.3M | $43.1M | $51.2M | $12.4M | $15.0M | $18.4M | $29.8M | $14.9M | $18.3M | $24.3M | $27.3M | $26.8M | $33.2M | $38.7M | $9.9M | $13.7M | $15.2M | $13.7M | $20.2M | $24.5M | $25.6M | $26.7M | $9.7M | $10.2M | $3.3M | $4.5M | $5.1M | $545.0K | $1.4M | $1.9M | $1.9M | $593.0K | $1.0M | $1.3M | $538.0K | $1.0M | $1.9M | $2.9M | $3.6M | $4.7M | $6.2M | $6.8M | $5.0M | $6.6M | $7.2M | $348.0K | $0.00 | ||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$2.6M | -$1.1M | -$1.1M | -$1.5M | -$544.0K | $7.0M | -$675.0K | -$544.0K | $4.5M | -$397.0K | -$488.0K | -$62.0K | -$391.0K | -$422.0K | -$323.0K | -$325.0K | -$469.0K | -$889.0K | -$407.0K | -$726.0K | -$1.1M | -$578.0K | -$636.0K | $1.8M | -$924.0K | -$550.0K | $6.8M | |||||||||||||||||||||||||||||||||||||
| Liabilities And Stockholders Equity | $49.3M | $44.9M | $46.4M | $58.9M | $63.2M | $69.2M | $19.4M | $21.8M | $30.4M | $15.6M | $19.1M | $26.0M | $28.1M | $27.8M | $34.1M | $39.3M | $10.4M | $15.9M | $17.8M | $20.7M | $24.9M | $25.7M | $26.8M | $9.9M | $10.3M | $3.3M | $4.6M | $5.1M | $588.0K | $1.5M | $1.9M | $1.9M | $673.0K | $1.0M | $1.4M | $640.0K | $1.0M | $1.9M | $2.9M | $3.6M | $4.8M | $6.3M | $6.8M | |||||||||||||||||||||
| Common Stock Value | $147.7M | $146.2M | $146.0M | $145.4M | $145.3M | $144.9M | $143.6M | $143.3M | $142.8M | $141.3M | $140.9M | $140.8M | $140.8M | $140.8M | $140.7M | $139.7M | $138.4M | $106.4M | $106.4M | $106.4M | $106.4M | $104.8M | $104.0M | $103.3M | $83.1M | $82.3M | $74.5M | $74.3M | $74.3M | $69.3M | $69.2M | $69.1M | $68.7M | $66.8M | $66.8M | $66.8M | $66.0M | $66.0M | $66.0M | $66.0M | $66.0M | $66.0M | $66.0M | $66.0M | ||||||||||||||||||||
| Additional Paid In Capital Common Stock | $71.2M | $69.1M | $67.7M | $65.8M | $64.1M | $63.2M | $61.2M | $60.4M | $57.9M | $56.6M | $54.6M | $53.6M | $52.0M | $51.1M | $49.8M | $49.1M | $49.2M | $48.7M | $47.8M | $47.5M | $45.5M | $45.1M | $45.1M | $44.0M | $43.6M | $42.9M | $42.2M | $41.9M | $41.8M | $41.7M | $41.6M | $41.6M | $41.6M | $41.0M | $40.0M | $39.5M | $38.5M | $38.4M | $38.4M | $38.1M | $38.1M | $38.1M | $38.0M | $37.9M | ||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | ||||||||||||||||||||
| Accrued Liabilities Current | $3.7M | $2.2M | $2.8M | $3.3M | $3.0M | $4.4M | $951.0K | $773.0K | $1.1M | $394.0K | $294.0K | $412.0K | $860.0K | $171.0K | $384.0K | $201.0K | $435.0K | $232.0K | $117.0K | $125.0K | $153.0K | $210.0K | $138.0K | $140.0K | $165.0K | $94.0K | $132.0K | $88.0K | $50.0K | $81.0K | $86.0K | $49.0K | $45.0K | $38.0K | $36.0K | $57.0K | $65.0K | $65.0K | $92.0K | $87.0K | $173.0K | $38.0K | $62.0K | $31.0K | ||||||||||||||||||||
| Accounts Payable Current | $5.9M | $5.9M | $5.3M | $3.9M | $4.4M | $5.2M | $2.9M | $3.0M | $2.9M | $2.5M | $1.7M | $1.2M | $1.2M | $677.0K | $2.5M | $2.7M | $2.8M | $1.7M | $788.0K | $1.2M | $1.3M | $1.9M | $709.0K | $1.0M | $492.0K | $296.0K | $224.0K | $235.0K | $345.0K | $225.0K | $252.0K | $401.0K | $384.0K | $364.0K | $335.0K | $154.0K | $315.0K | $716.0K | $698.0K | $315.0K | $276.0K | $374.0K | $414.0K | $239.0K | ||||||||||||||||||||
| Other Assets Current | $898.0K | $965.0K | $1.0M | $546.0K | $283.0K | $161.0K | $20.0K | $32.0K | $32.0K | $123.0K | $149.0K | $154.0K | $412.0K | $372.0K | $455.0K | $4.0K | $4.0K | $2.0K | $1.0K | $4.0K | $0.00 | $4.0K | $10.0K | $2.0K | $6.0K | $5.0K | $2.0K | $5.0K | $3.0K | $1.0K | $3.0K | $2.0K | $13.0K | $9.0K | $3.0K | $1.0K | $3.0K | $3.0K | $6.0K | $3.0K | $14.0K | $15.0K | $8.0K | |||||||||||||||||||||
| Assets | $49.3M | $44.9M | $46.4M | $58.9M | $63.2M | $69.2M | $19.4M | $21.8M | $30.4M | $15.6M | $19.1M | $26.0M | $28.1M | $27.8M | $34.1M | $39.3M | $10.4M | $15.9M | $17.8M | $20.7M | $25.7M | $26.8M | $9.9M | $10.3M | $3.3M | $4.6M | $5.1M | $588.0K | $1.5M | $1.9M | $1.9M | $673.0K | $1.0M | $1.4M | $640.0K | $1.0M | $1.9M | $2.9M | $3.6M | $4.8M | $6.3M | $6.8M | ||||||||||||||||||||||
| Liabilities | $53.8M | $52.3M | $52.3M | $64.1M | $64.5M | $66.2M | $29.6M | $29.2M | $29.2M | $27.6M | $7.0M | $6.6M | $7.0M | $5.8M | $2.1M | $847.0K | $1.2M | $1.0M | $580.0K | $427.0K | $360.0K | $451.0K | $345.0K | $431.0K | $759.0K | $1.1M | $3.9M | $5.7M | $5.7M | $4.8M | $3.5M | $11.0M | $1.6M | $1.6M | $2.2M | $9.9M | $7.5M | |||||||||||||||||||||||||||
| Common Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Liabilities Current | $9.8M | $8.4M | $8.4M | $7.4M | $7.7M | $9.8M | $3.9M | $3.8M | $4.0M | $2.9M | $3.0M | $2.1M | $2.0M | $848.0K | $2.9M | $2.9M | $3.2M | $1.9M | $905.0K | $1.4M | $1.5M | $2.1M | $847.0K | $1.2M | $1.0M | $580.0K | $427.0K | $360.0K | $451.0K | $345.0K | $431.0K | $759.0K | $1.1M | $3.9M | $5.7M | $5.7M | $11.0M | |||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$224.6M | -$224.0M | -$220.8M | -$217.7M | -$212.0M | -$206.4M | -$214.7M | -$209.3M | -$196.3M | -$188.3M | -$183.2M | -$175.1M | -$170.9M | -$166.9M | -$158.9M | -$152.7M | -$147.9M | -$140.4M | -$138.6M | -$133.9M | -$128.3M | -$125.5M | -$122.9M | -$119.1M | -$116.7M | -$115.1M | -$113.2M | $113.2M | -$112.0M | -$111.0M | -$110.9M | -$110.7M | ||||||||||||||||||||||||||||||||
| Derivative Liabilities Current | $0.00 | $0.00 | $0.00 | $373.0K | $190.0K | $71.0K | $37.0K | $56.0K | $39.0K | $93.0K | $309.0K | $694.0K | $3.5M | $5.3M | $5.5M | $4.4M | $2.7M | $10.2M | $1.2M | $1.1M | $1.8M | $9.5M | $7.2M | $10.5M | ||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.0M | $37.9M | -$5.4M | -$2.8M | -$3.0M | $542.0K | -$3.6M | -$5.6M | $28.8M | -$3.7M | -$2.2M | -$2.8M | -$2.6M | -$1.1M | -$1.1M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Repayments Of Long Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $21.9M | $18.7M | $22.7M | $40.3M | $43.1M | $51.2M | $12.4M | $15.0M | $18.4M | $29.8M | $14.9M | $18.3M | $24.3M | $27.3M | $26.8M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Gain On Deferred Lease Inducements | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Repayments Of Other Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Repayments Of Long Term Capital Lease Obligations | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $22.6M | -$13.6M | $6.6M | $20.7M | $5.0M | $32.3M | -$71.0K | $2.3M | $28.0M | $5.1M | $497.0K | $2.3M | $1.6M | $0.00 | $2.6M | $7.2M | |
| Investing Cash Flow * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Operating Cash Flow * | -$12.5M | $27.0M | -$17.1M | -$18.1M | -$14.2M | -$15.6M | -$9.1M | -$7.8M | -$3.6M | -$2.1M | -$1.9M | -$1.7M | -$2.2M | -$3.0M | -$3.2M | -$1.9M | |
| Share Based Compensation | $7.0M | $5.1M | $5.4M | $4.1M | $3.7M | $2.8M | $2.7M | $1.8M | $1.5M | $615.0K | $97.0K | $627.0K | $62.0K | $174.0K | $129.0K | $2.4M | |
| Increase Decrease In Prepaid Expenses Other | $658.0K | $505.0K | -$104.0K | -$264.0K | $237.0K | $163.0K | $58.0K | $40.0K | $85.0K | -$33.0K | $28.0K | -$33.0K | |||||
| Proceeds From Stock Options Exercised | $2.2M | $1.3M | $1.7M | $928.0K | $33.0K | $462.0K | $0.00 | $210.0K | $563.0K | $6.0K | $48.0K | $140.0K | $0.00 | $0.00 | $0.00 | ||
| Increase Decrease In Accrued Liabilities | $2.2M | -$326.0K | $576.0K | $1.3M | $101.0K | -$291.0K | $54.0K | -$17.0K | $497.0K | $33.0K | -$40.0K | $0.00 | |||||
| Increase Decrease In Accounts Payable | $1.4M | -$537.0K | $1.4M | $1.6M | -$794.0K | -$41.0K | $580.0K | $177.0K | $611.0K | -$54.0K | -$11.0K | $96.0K | |||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.0K | |||||||||||
| Increase Decrease In Operating Capital | -$120.0K | $365.0K | -$280.0K | $81.0K | -$116.0K | ||||||||||||
| Payments Of Stock Issuance Costs | $175.0K | $41.0K | $140.0K | $71.0K | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Proceeds From Issuance Of Common Stock | $32.0M | $0.00 | $0.00 | $27.4M | $5.0M | $0.00 | $2.2M | $1.6M | $0.00 | $2.6M | $7.2M | $683.0K | |||||
| Increase Decrease In Other Operating Assets | -$796.0K | -$3.0K | -$6.0K | $2.0K | $168.0K | $7.0K | -$12.0K | $10.0K | $2.0K | -$16.0K | $9.0K | ||||||
| Payments Of Financing Costs | $1.7M | $0.00 | $0.00 | $0.00 | |||||||||||||
| Proceeds From Payments For Other Financing Activities | $3.0K | $238.0K | $0.00 | $0.00 | $0.00 | ||||||||||||
| Proceeds From Sale Of Other Productive Assets | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Proceeds From Sale Of Short Term Investments | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Proceeds From Other Deposits | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Proceeds From Convertible Debt | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Payments To Acquire Intangible Assets | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Payments To Acquire Businesses And Interest In Affiliates | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Increase Decrease In Restricted Cash | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $359.0K | -$1.1M | $193.0K | $15.0K | $5.0M | -$117.0K | $31.9M | $0.00 | $0.00 | $0.00 | -$71.0K | $483.0K | $491.0K | $186.0K | $414.0K | $7.7M | $0.00 | $0.00 | $5.0M | $102.0K | $21.0K | $449.0K | $27.0K | $21.0K | $87.0K | $53.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.2M | ||||
| Investing Cash Flow * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Operating Cash Flow * | -$4.3M | $39.0M | -$5.6M | -$3.4M | -$2.9M | -$3.0M | -$4.4M | -$3.6M | -$5.4M | -$3.1M | -$3.7M | -$2.2M | -$2.8M | -$2.5M | -$1.6M | -$1.6M | -$1.7M | -$958.0K | -$688.0K | -$675.0K | -$544.0K | -$470.0K | -$499.0K | -$509.0K | -$511.0K | -$418.0K | -$443.0K | -$410.0K | -$378.0K | -$469.0K | -$889.0K | -$407.0K | -$726.0K | -$1.1M | -$578.0K | -$636.0K | $1.8M | -$1.0M | -$550.0K | -$386.0K |
| Share Based Compensation | $798.0K | $1.2M | $1.1M | $399.0K | $917.0K | $1.3M | $587.0K | $1.2M | $522.0K | $391.0K | $314.0K | $1.7M | $221.0K | $222.0K | $1.2M | $174.0K | $907.0K | $461.0K | $41.0K | $41.0K | $111.0K | $0.00 | $9.0K | $10.0K | $9.0K | $67.0K | $339.0K | $133.0K | $41.0K | $29.0K | $0.00 | $0.00 | $17.0K | $0.00 | $129.0K | $0.00 | $0.00 | $386.0K | $2.1M | |
| Increase Decrease In Prepaid Expenses Other | -$636.0K | $1.9M | -$131.0K | -$319.0K | $823.0K | -$210.0K | -$178.0K | $734.0K | -$54.0K | -$6.0K | $331.0K | -$52.0K | -$60.0K | $351.0K | -$47.0K | -$21.0K | $177.0K | -$11.0K | -$11.0K | $23.0K | -$22.0K | -$36.0K | $69.0K | -$17.0K | -$17.0K | $42.0K | -$29.0K | -$27.0K | ||||||||||||
| Proceeds From Stock Options Exercised | $371.0K | $627.0K | $213.0K | $15.0K | $24.0K | $21.0K | $449.0K | $27.0K | $21.0K | $87.0K | $53.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Increase Decrease In Accrued Liabilities | -$585.0K | $609.0K | -$924.0K | -$465.0K | $689.0K | -$213.0K | -$392.0K | -$55.0K | $24.0K | -$427.0K | -$8.0K | -$28.0K | -$452.0K | $72.0K | -$2.0K | -$482.0K | $71.0K | -$38.0K | $7.0K | $38.0K | -$31.0K | -$11.0K | $37.0K | $4.0K | -$87.0K | $2.0K | -$21.0K | -$75.0K | ||||||||||||
| Increase Decrease In Accounts Payable | $2.0M | $1.4M | $557.0K | $447.0K | $477.0K | -$1.8M | $937.0K | -$71.0K | $1.1M | $63.0K | -$440.0K | -$70.0K | $266.0K | $1.2M | -$324.0K | $178.0K | $196.0K | $71.0K | -$19.0K | -$110.0K | $120.0K | -$72.0K | -$149.0K | $17.0K | $76.0K | $30.0K | $180.0K | -$58.0K | ||||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $15.0K | $124.0K | ||||||||||||||||||||||
| Increase Decrease In Operating Capital | $14.0K | -$182.0K | $101.0K | $479.0K | -$10.0K | -$128.0K | $104.0K | -$62.0K | -$34.0K | -$129.0K | -$2.3M | $47.0K | $60.0K | -$57.0K | ||||||||||||||||||||||||||
| Payments Of Stock Issuance Costs | $42.0K | $117.0K | $23.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $32.0M | $0.00 | $0.00 | $102.0K | $27.0K | $21.0K | $87.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Increase Decrease In Other Operating Assets | $537.0K | $133.0K | -$8.0K | $2.0K | $1.0K | -$3.0K | $2.0K | -$6.0K | $2.0K | $2.0K | -$2.0K | $1.0K | -$15.0K | $4.0K | $6.0K | -$5.0K | ||||||||||||||||||||||||
| Payments Of Financing Costs | $1.7M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Proceeds From Payments For Other Financing Activities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Proceeds From Sale Of Other Productive Assets | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Proceeds From Sale Of Short Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Proceeds From Other Deposits | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Proceeds From Convertible Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Payments To Acquire Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Payments To Acquire Businesses And Interest In Affiliates | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Increase Decrease In Restricted Cash | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.34 | -$0.02 | -$0.60 | -$0.90 | -$0.67 | -$0.76 | -$0.64 | -$0.52 | -$0.47 | -$0.22 | -$0.06 | -$0.22 | $0.17 | -$0.21 | $0.19 | -$0.49 |
| Weighted Average Number Of Diluted Shares Outstanding | 28.6M | 27.3M | 26.6M | 26.3M | 26.0M | 23.7K | 9.9M | 10.6M | 25.2M | 24.1K | 16.0M | |||||
| Weighted Average Number Of Shares Outstanding Basic | 28.6M | 27.3M | 26.6M | 26.3M | 26.0M | 23.7K | 9.9M | 9.7M | 25.2M | 24.0K | 16.0M | |||||
| Earnings Per Share Basic | $-0.34 | $-0.02 | $-0.60 | $-0.90 | $-0.67 | $-0.76 | $-0.22 | $0.19 | $-0.21 | $0.20 | $-0.49 | |||||
| Common Stock Shares Outstanding | 34.2M | 27.5M | 27.0M | 26.4M | 26.0M | 26.0M | 19.9M | 19.9M | 18.4M | 13.6M | 10.9M | 10.6M | 9.7M | 25.2M | 25.2K | 20.5M |
| Common Stock Shares Issued | 34.2M | 27.5M | 27.0M | 26.4M | 26.0M | 26.0M | 19.9M | 19.9M | 18.4M | 13.6M | 10.9M | 10.6M | 9.7M | 25.2M | 25.2K | 20.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.02 | -$0.11 | -$0.04 | -$0.21 | -$0.20 | $0.41 | -$0.07 | -$0.21 | -$0.23 | -$0.31 | -$0.19 | -$0.14 | -$0.16 | -$0.15 | -$0.18 | -$0.24 | -$0.21 | -$0.19 | -$0.09 | -$0.24 | $0.14 | -$0.14 | -$0.14 | -$0.09 | -$0.15 | -$0.11 | -$0.06 | -$0.04 | -$0.06 | -$0.04 | -$0.01 | -$0.02 | $0.01 | $0.03 | -$0.08 | -$0.33 | -$0.21 | $0.26 | -$0.16 | -$0.03 | -$0.02 | $0.11 | -$0.17 | -$0.01 | $0.19 | $0.08 | -$0.01 |
| Weighted Average Number Of Diluted Shares Outstanding | 27.9M | 27.7M | 27.6M | 27.4M | 27.3M | 31.1M | 26.6M | 26.5M | 26.6M | 26.1M | 26.1M | 26.0M | 26.0M | 26.0M | 26.0M | 25.6M | 23.4M | 19.9M | 19.9M | 19.9M | 19.9M | 19.0M | 18.6M | 18.4M | 15.7M | 14.2M | 13.6M | 13.6M | 12.8M | 10.9M | 10.9M | 10.8M | 11.9M | 11.2M | 9.8M | 9.8M | 8.4M | 25.6M | 25.2M | 25.2M | 25.2K | 25.2K | 18.1M | 25.2M | 25.0M | 20.5M | 368.3M |
| Weighted Average Number Of Shares Outstanding Basic | 27.9M | 27.7M | 27.6M | 27.4M | 27.3M | 27.0M | 26.6M | 26.5M | 26.6M | 26.1M | 26.1M | 26.0M | 26.0M | 26.0M | 26.0M | 25.6M | 23.4M | 19.9M | 13.6M | 12.8M | 10.9M | 10.9M | 10.8M | 10.6M | 9.9M | 9.8M | 9.8M | 8.4M | 25.2M | 25.2M | 25.2M | 25.2K | 25.2K | 18.1M | 25.2M | 20.6M | 20.5M | 368.3M | |||||||||
| Earnings Per Share Basic | $-0.02 | $-0.11 | $-0.04 | $-0.21 | $-0.20 | $0.47 | $-0.07 | $-0.21 | $-0.23 | $-0.31 | $-0.19 | $-0.14 | $-0.16 | $-0.15 | $-0.18 | $-0.24 | $-0.21 | $-0.19 | $-0.09 | $-0.24 | $0.14 | $-0.14 | $-0.14 | $-0.09 | $-0.15 | $-0.11 | $-0.06 | $-0.04 | $-0.06 | $-0.04 | $-0.01 | $-0.02 | $0.02 | $0.04 | $-0.08 | $-0.33 | $0.11 | $0.23 | |||||||||
| Common Stock Shares Outstanding | 28.1M | 27.7M | 27.6M | 27.4M | 27.3M | 27.1M | 26.6M | 26.5M | 26.4M | 26.2M | 26.1M | 26.0M | 26.0M | 26.0M | 26.0M | 25.8M | 25.4M | 19.9M | 19.9M | 19.9M | 19.9M | 19.1M | 18.8M | 18.5M | 15.9M | 15.6M | 13.6M | 13.6K | 13.6M | 11.0M | 10.9M | 10.9M | 10.6K | 9.9K | 29.5K | 29.3M | 0.00 | 0.00 | 25.2K | 25.2M | 25.2M | 25.2M | 25.2M | 452.9M | |||
| Common Stock Shares Issued | 28.1M | 27.7M | 27.6M | 27.4M | 27.3M | 27.1M | 26.6M | 26.5M | 26.4M | 26.2M | 26.1M | 26.0M | 26.0M | 26.0M | 26.0M | 25.8M | 25.4M | 19.9M | 19.9M | 19.9M | 19.9M | 19.1M | 18.8M | 18.5M | 15.9M | 15.6M | 13.6M | 13.6K | 13.6M | 11.0M | 10.9M | 10.9M | 10.6K | 9.9K | 29.5K | 29.3M | 0.00 | 0.00 | 25.2K | 25.2M | 25.2M | 25.2M | 25.2M | 452.9M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Issuance Of Stock And Warrants For Services Or Claims | $133.0K | $266.0K | $84.0K | $417.0K | $272.0K | $741.0K | $88.0K | $0.00 | $434.0K | $25.0K | $152.0K | $121.0K | $53.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $2.2M | $1.3M | $1.7M | $1.6M | $33.0K | $462.0K | $210.0K | $563.0K | $6.0K | $48.0K | $140.0K | |||||
| Prepaid Expense Current | $3.7M | $3.1M | $2.6M | $770.0K | $1.0M | $797.0K | $226.0K | $168.0K | $128.0K | $43.0K | $76.0K | $48.0K | $81.0K | $56.0K | $35.0K | $38.0K |
| Unrealized Gain Loss On Derivatives | $0.00 | $167.0K | -$134.0K | $48.0K | $1.2M | $355.0K | $3.8M | |||||||||
| Foreign Currency Transaction Gain Loss Unrealized | $28.0K | -$82.0K | $5.0K | -$9.0K | -$10.0K | $0.00 | $9.0K | -$36.0K | ||||||||
| Gain Loss On Derivative Instruments Net Pretax | $0.00 | $349.0K | $0.00 | -$1.6M | $8.1M | -$3.3M | ||||||||||
| Stock Issued During Period Value New Issues | $42.0M | $32.0M | $27.4M | $5.0M | $2.2M | |||||||||||
| Amortization Of Tenant Inducements Received | $0.00 | $0.00 | $0.00 | |||||||||||||
| Other Noncash Expense | $0.00 | $0.00 | $0.00 | |||||||||||||
| Gain Loss Related To Litigation Settlement | $0.00 | $0.00 | $0.00 | |||||||||||||
| Depreciation And Amortization | $0.00 | $0.00 | $0.00 | |||||||||||||
| Stock Issued During Period Value Stock Warrants Exercised | $2.1M | $31.0K | $102.0K | $449.0K | $21.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Issuance Of Stock And Warrants For Services Or Claims | $34.0K | $9.0K | $21.0K | $21.0K | $21.0K | $21.0K | $331.0K | $43.0K | $46.0K | $83.0K | $114.0K | $210.0K | $286.0K | $56.0K | $28.0K | $17.0K | $13.0K | $0.00 | $0.00 | $0.00 | $122.0K | $0.00 | $129.0K | $27.0K | $0.00 | $0.00 | $3.0K | $35.0K | $0.00 | $29.0K | $49.0K | $0.00 | |||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $1.4M | $186.0K | $371.0K | $157.0K | $347.0K | $627.0K | $215.0K | $541.0K | $213.0K | $188.0K | $46.0K | $15.0K | $23.0K | $0.00 | $139.0K | $35.0K | $36.0K | $383.0K | $98.0K | $6.0K | $21.0K | $27.0K | $87.0K | $53.0K | |||||||||||||||||||||||
| Prepaid Expense Current | $1.4M | $1.4M | $2.4M | $3.1M | $4.4M | $4.5M | $457.0K | $639.0K | $278.0K | $490.0K | $715.0K | $1.2M | $409.0K | $619.0K | $900.0K | $166.0K | $220.0K | $387.0K | $56.0K | $108.0K | $411.0K | $60.0K | $107.0K | $198.0K | $21.0K | $32.0K | $41.0K | $18.0K | $40.0K | $83.0K | $14.0K | $31.0K | $67.0K | $25.0K | $54.0K | $101.0K | $20.0K | $39.0K | $64.0K | $11.0K | $24.0K | $82.0K | $12.0K | ||||
| Unrealized Gain Loss On Derivatives | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $167.0K | -$183.0K | -$120.0K | -$37.0K | $19.0K | -$17.0K | $43.0K | $216.0K | $385.0K | $625.0K | $619.0K | $181.0K | -$2.7M | -$1.7M | $7.5M | -$3.6M | -$139.0K | $645.0K | -$2.2M | $225.0K | $2.6M | |||||||||||||||||||||
| Foreign Currency Transaction Gain Loss Unrealized | -$3.0K | $17.0K | $13.0K | -$17.0K | -$38.0K | -$11.0K | $5.0K | $9.0K | -$4.0K | $1.0K | -$3.0K | -$1.0K | -$4.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $13.0K | -$10.0K | ||||||||||||||||||||||
| Gain Loss On Derivative Instruments Net Pretax | $0.00 | $625.0K | $379.0K | $181.0K | -$2.7M | -$1.7M | $7.5M | -$3.6M | -$139.0K | $645.0K | $3.3M | -$2.2M | $225.0K | $5.7M | $2.6M | -$72.0K | |||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $32.0M | $7.6M | $5.0M | ||||||||||||||||||||||||||||||||||||||||||||
| Amortization Of Tenant Inducements Received | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||
| Other Noncash Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||
| Gain Loss Related To Litigation Settlement | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||
| Depreciation And Amortization | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Stock Warrants Exercised | $344.0K | $438.0K | $150.0K | $31.0K | $102.0K | $449.0K | $21.0K | $0.00 |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.